. 2018 Nov 3;28(6):819–834. doi: 10.1007/s00787-018-1247-4

Table 3.

Scores Y-OQ-30 at T1 start, T2, T3, T4 and T5

	Care as usual			FIT 3–8 sessions			FIT 9 + sessions			Linear mixed-effects with repeated measures
	(n = 80)			(n = 41)			(n = 45)			TIME				GROUP				Interaction TxG^F
	N	Mean	±SD	N	Mean	±SD	N	Mean	±SD	Post hoc comparison	df₁, df₂	F	p value	Post hoc comparison	df₁, df₂	F	p value	df₁, df₂	F	p value
Somatic complaints
Start	71	3.6	± 2.6	31	3.9	± 3.3	37	4.6	± 2.9	Start (ref.)	4, 413	6.55	0.000	CAU (ref.)	2, 159	1.69	0.188	8, 413	0.53	0.835
3 months	43	3.1	± 2.8	27	3.8	± 2.7	32	4.8	± 3.0	3 months				3–8 sessions
6 months	43	3.1	± 2.6	29	3.4	± 2.5	33	3.9	± 2.9	6 months *				9 + sessions
9 months	47	2.8	± 2.5	24	3.9	± 2.8	27	3.6	± 2.4	9 months
End	53	3.0	± 3.1	30	3.3	± 2.6	36	3.6	± 2.8	End ***
Social isolation
Start	71	2.6	± 2.0	31	3.4	± 2.5	37	3.3	± 2.2	Start (ref.)	4, 413	5.17	0.000	CAU (ref.)	2, 156	2.70	0.070	8, 414	1.29	0.247
3 months	43	2.8	± 2.1	27	3.9	± 2.4	32	3.1	± 1.8	3 months				3–8 sessions
6 months	43	2.6	± 2.2	29	3.8	± 1.7	33	2.6	± 2.1	6 months				9 + sessions
9 months	47	2.7	± 2.0	24	2.9	± 1.9	27	2.4	± 2.2	9 months
End	53	2.3	± 2.0	30	3.2	± 2.2	36	2.1	± 1.7	End **
Aggression
Start	71	2.2	± 2.6	31	2.4	± 3.0	37	2.5	± 2.3	Start (ref.)	4, 412	8.47	0.000	CAU (ref.)	2, 159	0.56	0.575	8, 413	1.37	0.205
3 months	43	2.1	± 2.5	27	2.1	± 3.1	32	1.5	± 1.7	3 months				3–8 sessions
6 months	43	2.1	± 2.5	29	1.9	± 2.4	33	1.6	± 1.9	6 months				9 + sessions
9 months	47	1.9	± 2.4	24	1.6	± 2.7	27	1.4	± 1.7	9 months
End	53	1.8	± 2.5	30	0.9	± 1.3	36	1.3	± 1.6	End ***
Behavioral problems
Start	71	7.4	± 5.0	31	6.7	± 5.3	37	6.8	± 4.3	Start (ref.)	4, 410	13.00	0.000	CAU (ref.)	2, 160	1.65	0.195	8, 410	0.96	0.463
3 months	43	6.7	± 4.6	27	6.6	± 6.2	32	5.9	± 3.4	3 months				3–8 sessions
6 months	43	6.1	± 4.7	29	6.8	± 4.8	33	5.4	± 3.4	6 months *				9 + sessions
9 months	47	6.6	± 4.8	24	5.5	± 4.6	27	4.3	± 3.2	9 months **
End	53	5.9	± 4.5	30	4.7	± 3.9	36	4.3	± 3.1	End ***
Hyperactivity and concentration problems
Start	71	7.3	± 2.6	31	6.8	± 3.0	37	6.9	± 3.2	Start (ref.)	4, 415	18.03	0.000	CAU (ref.)	2, 163	2.41	0.093	8, 416	1.97	0.049
3 months	43	7.1	± 2.9	27	6.1	± 2.6	32	6.7	± 2.9	3 months				3–8 sessions
6 months	43	6.4	± 2.7	29	6.2	± 2.6	33	6.2	± 2.6	6 months ***				9 + sessions
9 months	47	6.7	± 2.3	24	5.8	± 2.5	27	4.9	± 2.9	9 months ***
End	53	6.7	± 2.6	30	5.3	± 2.9	36	5.2	± 2.6	End ***
Depression and fear
Start	71	6.2	± 3.5	31	8.1	± 5.3	37	8.1	± 4.7	Start (ref.)	4, 413	11.50	0.000	CAU (ref.)	2, 160	3.55	0.031	8, 413	1.93	0.054
3 months	43	5.7	± 3.6	27	7.3	± 5.3	32	8.7	± 5.0	3 months				3–8 sessions*
6 months	43	5.5	± 3.6	29	7.8	± 4.9	33	7.2	± 4.4	6 months				9 + sessions *
9 months	47	6.1	± 3.1	24	7.7	± 5.0	27	6.4	± 3.7	9 months
End	53	5.3	± 3.5	30	5.8	± 3.9	36	5.9	± 3.8	End ***
Total score
Start	71	38.4	± 15.6	31	40.5	± 19.8	37	42.3	± 15.3	Start (ref.)	4, 409	23.89	0.000	CAU (ref.)	2, 158	0.19	0.825	8, 409	1.71	0.093
3 months	43	36.0	± 16.5	27	38.6	± 21.6	32	39.3	± 15.4	3 months				3–8 sessions
6 months	43	34.0	± 16.2	29	38.3	± 15.8	33	34.8	± 15.3	6 months ***				9 + sessions
9 months	47	34.4	± 13.6	24	36.3	± 18.8	27	30.4	± 14.0	9 months ***
End	53	32.9	± 13.8	30	30.6	± 14.0	36	29.4	± 13.5	End ***

Results linear mixed-effects analysis

T main effect for time, G main effect for group, TxG time × group interaction, F False Discovery Rate correction for multiple comparisons, Y-OQ-30 higher scores means more problems

*p < 0.05; **p < 0.005; ***p < 0.0001